ARWR
Arrowhead Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$55.05
+0.04 ▲ +0.07%
🌙 3월 13일 7:50 PM ET (한국 3/14 08:50)
$54.60
-0.45 ▼ -0.82%
| Index | RUT | P/E | 35.79 | EPS (ttm) | 1.54 | Insider Own | 6.57% | Shs Outstand | 0.14B | Perf Week | -7.97% |
| Market Cap | 7.71B | Forward P/E | - | EPS next Y | -27.19% | Insider Trans | -5.7% | Shs Float | 0.13B | Perf Month | -10.56% |
| Enterprise Value | 7.47B | PEG | - | EPS next Q | -1.04 | Inst Own | 81.16% | Short Float | 8.52% | Perf Quarter | -20.07% |
| Income | 0.20B | P/S | 7.07 | EPS this Y | -32007.08% | Inst Trans | 2.48% | Short Ratio | 3.92 | Perf Half Y | 85.23% |
| Sales | 1.09B | P/B | 13.31 | EPS next 5Y | - | ROA | 15.45% | Short Interest | 11.14M | Perf YTD | -17.08% |
| Book/sh | 4.14 | P/C | 8.41 | EPS past 3/5Y | 80.6% 57.1% | ROE | 65.14% | 52W High | -28.28% ($76.76) | Perf Year | 265.3% |
| Cash/sh | 6.55 | P/FCF | 23.57 | Sales past 3/5Y | 50.52% 56.63% | ROIC | 16.73% | 52W Low | 475.24% ($9.57) | Perf 3Y | 108.36% |
| Dividend Est. | - | EV/EBITDA | 22.95 | EPS Y/Y TTM | 130.44% | Gross Margin | 97.7% | Volatility(W/M) | 5.64% 4.85% | Perf 5Y | -24.32% |
| Dividend TTM | - | EV/Sales | 6.85 | Sales Y/Y TTM | 43539.24% | Oper. Margin | 27.55% | ATR (14) | 3.37 | Perf 10Y | 1126.06% |
| Dividend Ex-Date | - | Quick Ratio | 3.38 | EPS Q/Q | 115.8% | Profit Margin | 18.54% | RSI (14) | 30.01 | Recom | 1.69 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.38 | Sales Q/Q | 10461.32% | SMA20 | -11.17% ($61.97) | Beta | 1.33 | Target Price | $81.7 |
| Payout | - | Debt/Eq | 1.21 | Earnings | 2000000 | SMA50 | -14.79% ($64.61) | Rel Volume | 1.58 | Prev Close | $55.01 |
| Employees | 711 | LT Debt/Eq | 1.13 | EPS/Sales Surpr. | 491.4% 23.41% | SMA200 | 36.29% ($40.39) | Avg Volume(3M) | 2.84M | Price | $55.05 |
| IPO | 1993/12/16 | Option/Short | Yes/Yes | Trades | 21992 | Volume | 4,477,182 | Change | 0.07% |
뉴스 로딩 중...